Plavix Pharmacogenomic Label Update May Help Lilly With Effient Launch

When Lilly's Effient (prasugrel) finally cleared FDA July 10, the first thing everyone noticed is the "black box" warning of a potential increased risk of bleeding associated with the antithrombotic drug